Mario Gabelli's EVH Position Overview
Mario Gabelli (via Gamco Investors, Inc. Et Al) currently holds 289,500 shares of Evolent Health, Inc. (EVH) worth $660,060, representing 0.01% of the portfolio. First purchased in 2017-Q3, this long-term strategic position has been held for 35 quarters.
Based on 13F filings, Mario Gabelli has maintained a strategic position in EVH, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2017, adding 91,000 shares. Largest reduction occurred in Q2 2020, reducing 154,003 shares.
Analysis based on 13F filings available since 2013 Q2
Mario Gabelli's Evolent Health (EVH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Evolent Health (EVH) Trades by Mario Gabelli
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +12,000 | Add 4.32% | 289,500 | $2.28 |
| Q4 2025 | +33,500 | Add 13.73% | 277,500 | $4.00 |
| Q3 2025 | -1,200 | Reduce 0.49% | 244,000 | $8.46 |
| Q2 2025 | -2,300 | Reduce 0.93% | 245,200 | $11.26 |
| Q1 2025 | +50,400 | Add 25.57% | 247,500 | $9.47 |
| Q4 2024 | +60,000 | Add 43.76% | 197,100 | $11.25 |
| Q3 2024 | +5,300 | Add 4.02% | 137,100 | $28.28 |
| Q2 2024 | +34,800 | Add 35.88% | 131,800 | $19.12 |
| Q3 2023 | +500 | Add 0.52% | 97,000 | $27.23 |
| Q3 2022 | -3,400 | Reduce 3.40% | 96,500 | $35.93 |
| Q2 2022 | -4,600 | Reduce 4.40% | 99,900 | $30.71 |
| Q1 2022 | -2,000 | Reduce 1.88% | 104,500 | $32.30 |
| Q3 2021 | -16,500 | Reduce 13.41% | 106,500 | $31.00 |
| Q1 2021 | -16,000 | Reduce 11.51% | 123,000 | $20.20 |
| Q4 2020 | -16,000 | Reduce 10.32% | 139,000 | $16.03 |
| Q3 2020 | -4,000 | Reduce 2.52% | 155,000 | $12.41 |
| Q2 2020 | -154,003 | Reduce 49.20% | 159,000 | $7.12 |
| Q4 2019 | +35,000 | Add 12.59% | 313,003 | $9.05 |
| Q3 2019 | +34,000 | Add 13.93% | 278,003 | $7.19 |
| Q2 2019 | +21,600 | Add 9.71% | 244,003 | $7.95 |
| Q1 2019 | +39,500 | Add 21.60% | 222,403 | $12.58 |
| Q4 2018 | +10,500 | Add 6.09% | 182,903 | $19.95 |
| Q3 2018 | -9,700 | Reduce 5.33% | 172,403 | $28.40 |
| Q2 2018 | +100 | Add 0.05% | 182,103 | $21.05 |
| Q1 2018 | +16,000 | Add 9.64% | 182,003 | $14.25 |
| Q4 2017 | +91,000 | Add 121.33% | 166,003 | $12.30 |
| Q3 2017 | +75,003 | New Buy | 75,003 | $17.80 |
Mario Gabelli's Evolent Health Investment FAQs
Mario Gabelli first purchased Evolent Health, Inc. (EVH) in Q3 2017, acquiring 75,003 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mario Gabelli has held Evolent Health, Inc. (EVH) for 35 quarters since Q3 2017.
Mario Gabelli's largest addition to Evolent Health, Inc. (EVH) was in Q4 2017, adding 166,003 shares worth $2.04 M.
According to the latest 13F filing for Q1 2026, Mario Gabelli's firm, Gamco Investors, Inc. Et Al, owns 289,500 shares of Evolent Health, Inc. (EVH), valued at approximately $660,060.
As of the Q1 2026 filing, Evolent Health, Inc. (EVH) represents approximately 0.01% of Mario Gabelli's publicly disclosed stock portfolio, making it one of their key holdings.
Mario Gabelli's peak holding in Evolent Health, Inc. (EVH) was 313,003 shares, as reported at the end of Q4 2019.